Related Experiment Video
Updated: May 3, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus
Kulandaipalayam N C Sindhu1, Thuppal V Sowmyanarayanan, Anu Paul
1Division of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India.
Insights
Lactobacillus rhamnosus GG (LGG) probiotic reduced repeated diarrhea episodes and improved intestinal function in Indian children with rotavirus and cryptosporidial gastroenteritis.
Area of Science:
- Pediatric Gastroenterology
- Immunology
- Microbiology
Background:
- Probiotics, including Lactobacillus rhamnosus GG (LGG), are being investigated for their potential role in managing pediatric acute gastroenteritis.
- This study focuses on the effects of LGG on intestinal function, immune response, and clinical outcomes in Indian children suffering from rotavirus or cryptosporidial diarrhea.
Purpose of the Study:
- To evaluate the efficacy of Lactobacillus rhamnosus GG (LGG) in treating rotavirus and cryptosporidial diarrhea in children.
- To assess the impact of LGG on intestinal permeability, immune response (IgG, IgA), and recurrence of diarrheal episodes.
Main Methods:
- A randomized controlled trial involving 124 children (6 months to 5 years) with confirmed rotavirus or cryptosporidial diarrhea.
- Participants received either LGG or a placebo daily for 4 weeks. Intestinal permeability (lactulose to mannitol ratio) and serum antibody levels (IgG, IgA) were measured at baseline and follow-up.
Main Results:
- LGG supplementation was associated with a significant reduction in repeated diarrheal episodes (25% vs. 46%) and improved intestinal function (48% vs. 72%) in children with rotavirus diarrhea.
- Children with rotavirus diarrhea receiving LGG showed a significant increase in IgG antibody levels.
- Significant improvement in intestinal permeability was observed in children with cryptosporidial diarrhea treated with LGG.
Conclusions:
- Lactobacillus rhamnosus GG (LGG) demonstrates a positive immunomodulatory effect, potentially reducing rotavirus diarrhea recurrence.
- Probiotics like LGG play a crucial role in restoring intestinal function following viral or parasitic gastroenteritis in children.
Background:
Probiotics have a possible role in the treatment of pediatric acute gastroenteritis. We report the effect of the probiotic Lactobacillus rhamnosus GG (LGG) on intestinal function, immune response, and clinical outcomes in Indian children with cryptosporidial or rotavirus diarrhea.
Methods:
Children with gastroenteritis aged 6 months to 5 years, testing positive for either rotavirus or Cryptosporidium species in stool (coinfections were excluded), were randomized to LGG (ATCC 53103) or placebo, once daily for 4 weeks. Baseline demographic and clinical details were obtained. Sera were tested for immunoglobulin G (IgG) and immunoglobulin A (IgA) antibodies to Cryptosporidium and rotavirus, and the lactulose to mannitol ratio for intestinal permeability was determined at baseline and at the end of follow-up.
Results:
Of the 124 children enrolled, 82 and 42 had rotavirus and cryptosporidial diarrhea, respectively. Median diarrheal duration was 4 days; one-third of the children had severe diarrhea. Baseline and clinical parameters were comparable between children receiving LGG and placebo. At the end of follow-up, fewer children with rotavirus diarrhea on LGG had repeated diarrheal episodes (25% vs 46%; P = .048) and impaired intestinal function (48% vs 72%; P = .027). Significant increase in IgG levels postintervention (456 vs 2215 EU; P = .003) was observed in children with rotavirus diarrhea receiving LGG. Among children with cryptosporidial diarrhea, those receiving LGG showed significant improvement in intestinal permeability.
Conclusions:
LGG has a positive immunomodulatory effect and may be useful in decreasing repeated episodes of rotavirus diarrhea. Improvement in intestinal function in children with rotavirus and cryptosporidial gastroenteritis emphasizes the role of probiotics in treating intestinal impairment after infection.
Clinical Trials Registration:
CTRI/2010/091/000339.
More Related Videos
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
07:18Oral Gavage in Neonatal Mouse Pups and Functional Assessment of Gut Barrier Integrity Using Ussing Chambers
Published on: January 9, 2026
Related Concept Videos
Probiotics
Microbiota of the Stomach and Small Intestine